Ongoing Monoclonal Antibodies and Plasmids Services through GENSCRIPT
Closed Pre-Solicitation Posted
- Solicitation number
- NOI-NIAID-25-2253129
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Place of performance
- Rockville, Maryland 20852, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health intends to sole source a contract with GenScript USA Inc for ongoing monoclonal antibodies and plasmids services. Specifically, the Antibody Biology Unit of the Laboratory of Immunogenetics requires custom Gene to Antibodies, plasmid heavy chain, and plasmid light chain preparation services to advance knowledge of human B cells and potentially design new influenza vaccine candidates. The procurement will be conducted through the NIAID electronic Simplified Acquisition Submission System (eSASS), with all capability statements due by January 3, 2025, at 5:00 pm ET. Vendors must register in the eSASS system to submit documentation, and the government retains sole discretion to determine whether to compete the requirement based on responses. The statutory authority for this sole source procurement is 41 U.S.C. 1901(a)(1), with justification that only one responsible source can satisfy agency requirements.
The pre-solicitation notice indicates no specific set-aside designation for this contract opportunity. The procurement is categorized under NAICS code 541380 for Testing Laboratories and Services, with a PSC code of Q301 for Reference Laboratory Testing. GenScript USA Inc of Piscataway, NJ is the incumbent and proposed sole source contractor, continuing a master project that requires additional work and necessitates continuity to retain comparative research results. While no specific award value or budget range is detailed in the notice, the contract appears to be for ongoing scientific services supporting vaccine research. The procurement represents a continuation of existing work with GenScript, suggesting an established relationship and specialized service requirements that are critical to the NIAID's immunological research objectives.
Notice text
PRE-SOLICITATION NOTICE **NOTICE OF INTENT TO SOLE SOURCE
NOI-NIAID-25-2253129
NAICS – 541380, Testing Services
This is a Notice of Intent, not a request for proposal. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with GenScript USA Inc of Piscataway, NJ to procure ongoing monoclonal antibodies and plasmids services for the NIAID Laboratory of Immunogenetics (LIG).
The National Institute of Allergy and Infectious Diseases (NIAID) Antibody Biology Unit (ABU) of the Laboratory of Immunogenetics (LIG), in furtherance of its mission to advance knowledge of human B cells and isolation of monoclonal antibodies, requires a service that provides custom Gene to Antibodies, plasmid heavy chain, and plasmid light chain preparation. These custom antibody and plasmid services can be used to design new vaccine candidates against influenza. The Antibody Biology Unit (ABU) has using GenScript for custom gene to antibody, plasmid heavy chain, and plasmid light chain services, and this is continuation of a master project that requires some additional work. Continuity is required to retain comparison of results.
The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide comparable services may submit a capability statement. All required documents must be submitted via the NIAID electronic Simplified Acquisition Submission System (eSASS) website at https://esass.nih.gov by January 3, 2025 at 5:00 pm ET. All vendors must register in the eSASS system to submit their documentation. Instructions on how to register /submit documents are included on the website. All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity